Tag: Big Pharma

From The New York Times: Singulair, now a generic, is still used by millions of Americans even after thousands of patients and dozens of studies have described harm. Children face the greatest risks of the drug's ill effects.

An analysis of the huge increase in drugs for children, the role of Big Pharma, and a look at the impact on families and communities.

Malcharist, by Paul John Scott, is a fictional account of one of psychiatry’s most influential key opinion leaders (KOLs), his ghostwriter, and a journalist on the trail of a big scandal in the world of Big Pharma.

The UK’s Medicines & Healthcare Products Regulatory Agency is refusing to respond to the concerns of psychiatrists, parliamentarians, patients and other experts about the impending licensing of the street drug ketamine as a treatment for depression.

MIA's Gavin Crowell-Williamson interviews PharmedOut founder Dr. Adriane Fugh-Berman about Big Pharma's influence on medical education.

An interview with Professor Sami Timimi, Psychiatrist Peter Gordon and campaigner Stevie Lewis, who talk about the potential for conflicts of interest with the UK Royal College of Psychiatrists participation in a Government-led review of Prescribed Drug Dependence.

Sergio Sismondo's new book from Mattering Press explores how Big Pharma controls drug research and marketing at every stage, maximizing industry profits at the expense...

From NPR: "A Center for Public Integrity and NPR investigation found drug companies have infiltrated nearly every part of the process that determines how their drugs will be covered...

From Bloomberg: "The counterattack against the drug has been furious, and in many instances led by women. These forces contend that one woman’s sexual abnormal...

From Yahoo! News: "There’s a substantial body of medical literature dating back to the early ’90s about the practice known as 'disease mongering.' Pharmaceutical companies...

From ProPublica: "The FDA is increasingly green-lighting expensive drugs despite dangerous or little-known side effects and inconclusive evidence that they curb or cure disease. Once...

From Medium: "This is where evidence based medicine is supposed to shine, by demanding randomized trials to prove that certain procedures/drugs either work or don’t....

The US/Canadian Pharmaceutical Policy Reform Working Group proposes universal drug coverage and ambitious reforms to the pharmaceutical system.

From Medical Xpress: A group of 21 prominent physicians have released a comprehensive proposal to guarantee everyone access to safe, innovative, and affordable medication. The proposed reforms...

From Bloomberg: The Pharmaceutical Research and Manufacturers of America (PhRMA) spent $9.96 million on federal lobbying in the first three months of 2018, representing an...

In this piece for Vision Magazine, Danit Felber details the U.S. pharmaceutical industry's efforts to stomp out foreign competition. "What does this mean practically? A nonprofit...

Kaiser Health News has launched a new database called Pre$scription for Power, which exposes donations pharmaceutical companies have made to patient advocacy groups. The...

From Medium: According to many prominent physicians, so-called "evidence based medicine" is no longer useful. Much of the evidence base has been corrupted by the...

In this piece for the Monthly Review, Joel Lexchin details four strategies that the pharmaceutical industry is utilizing in order to maintain its high level...

An exclusive analysis by CNN and researchers at Harvard University found that opioid manufacturers are paying physicians huge sums of money — and that doctors with higher...

From STAT: Last month, Senator Claire McCaskill released a report showing that opioid manufacturers had funneled nearly $9 million to patient advocacy groups between 2012...

From HealthNewsReview.org: In light of the opioid crisis, lawmakers are growing increasingly concerned about financial conflicts of interest in patient advocacy groups. Ontario has enacted...

From The Health Law & Policy Brief: Last month, Patient Services Inc. (PSI), a pharmaceutical industry-funded charity, launched a lawsuit against the Department of Health...

From The Washington Post: In 2017, numerous politicians, advocacy groups, and other stakeholders began to raise questions about the rising costs of prescription drugs. Under attack,...

From The Hill: The pharmaceutical industry's top trade group, the Pharmaceutical Research and Manufacturers of America (PhRMA), has increased its federal lobbying expenditures by 30...